Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2472a824f4490c0

Jump to content

// Workers AI · dad joke modeWhy did NORML France go to the party? It was a joint effort.

From Wikipedia, the free encyclopedia
NORML France
Chanvre & Libertés
Founded1995
FoundersOlivier Bertrand MD
Farid Ghehiouèche
FocusLegalization or decriminalization of marijuana in France
Location
Region served
France
Websitewww.norml.fr

NORML France (/ˈnɔːrməl/, the National Organization for the Reform of Marijuana Laws), previously known as Chanvre & Libertés - NORML France (Hemp & Freedom - NORML France) is a French non-profit organization based in Toulouse but active in all territories of France, whose aim is to move public opinion sufficiently to achieve the depenalization of illicit drugs consumption, the legalization of non-medical marijuana and the increased access to medical cannabis in France, so that the responsible use of cannabis by adults is no longer subject to penalty.

The organization operated a re-foundation in 2013, after the fusion of several regional groups of cannabis policy reform advocacy or activism (among which the older was created 1995).

Initially involved on international drug policy reform issues, NORML France split in 2016 part of its activity to focus on national cannabis-related actions, letting the newly created FAAAT think & do tank handle international advocacy and coordinate collective action at the international level.[1]

Other branches of NORML

[edit]

See also

[edit]

References

[edit]
  1. Susan Mayor (2019-02-05). "WHO proposes rescheduling cannabis to allow medical applications". BMJ. 364. British Medical Journal: l574. doi:10.1136/bmj.l574. PMID 30723076. S2CID 73449383. Retrieved 2019-02-06.
[edit]